Granulocytemonocyte

Granulocytemonocyte is a term encountered in some texts to describe a common progenitor cell in adult hematopoiesis that can give rise to both granulocytes and monocytes. In current standard nomenclature, this lineage stage is more commonly called the granulocyte–monocyte progenitor (GMP). The GMP sits downstream of the common myeloid progenitor (CMP) in the bone marrow and serves as a branching point for the granulocyte and monocyte lineages, including neutrophils, eosinophils, basophils, as well as monocytes, macrophages, and dendritic cells.

Development and differentiation are driven by cytokines and transcription factors. Granulocytic differentiation is promoted by factors such as granulocyte colony-stimulating factor (G-CSF) and related signaling, while monocyte/macrophage pathways are guided by macrophage colony-stimulating factor (M-CSF) and related cues. Transcription factors such as PU.1 and members of the C/EBP family play important roles in coordinating lineage choice and maturation within this progenitor pool.

Phenotypically, GMPs are proliferative marrow cells that do not express mature erythroid or megakaryocytic markers and exhibit characteristics of early myeloid progenitors. In humans, GMPs are typically defined by a combination of surface markers used in flow cytometry, with exact marker panels varying across studies.

Clinical relevance and research context: Variations in GMP numbers or function have been associated with disorders of myelopoiesis, including myelodysplastic syndromes and certain leukemias, and GMP biology is investigated to understand immune cell development and to inform therapeutic strategies in cancer and infectious diseases.

See also: granulocyte, monocyte, hematopoiesis, granulocyte–monocyte progenitor (GMP).